Tomoyuki Sumizawa
- Oncology top 0.5%
- Drug Transport and Resistance Mechanisms 54
- Cancer-related Molecular Pathways 7
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 11
- Molecular Biology top 5%
- Cancer therapeutics and mechanisms 12
- Glycosylation and Glycoproteins Research 7
- DNA Repair Mechanisms 7
-
- Pharmacological Effects and Toxicity Studies 10
- Biochemistry top 5%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 7
- Co-authors
- Tatsuhiko FurukawaShin‐ichi AkiyamaZhe‐Sheng ChenMisako HaraguchiShin-ichi AkiyamaTakashi AikouKazutaka MiyaderaS Akiyama
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Tomoyuki Sumizawa
94 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 111
- Oncology 2.7k
- Cancer Research 813
- Molecular Biology 2.2k
- Pediatrics, Perinatology and Child Health 471
- Biochemistry 153
Countries citing papers authored by Tomoyuki Sumizawa
This map shows the geographic impact of Tomoyuki Sumizawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Sumizawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Sumizawa more than expected).
Fields of papers citing papers by Tomoyuki Sumizawa
This network shows the impact of papers produced by Tomoyuki Sumizawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Sumizawa. The network helps show where Tomoyuki Sumizawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tomoyuki Sumizawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 21 | |
| 2 | 2010 | 50 | |
| 3 | 2009 | 11 | |
| 4 | 2006 | 7 | |
| 5 | 2005 | 30 | |
| 6 | 2004 | 13 | |
| 7 | 2004 | 31 | |
| 8 | 2003 | 63 | |
| 9 | 機能的な肺耐性関連タンパク質(LRP)の発現により予測される成人T細胞白血病(ATL)の不良転帰 | 2001 | 2 |
| 10 | 2000 | 25 | |
| 11 | 1999 | 15 | |
| 12 | 1999 | 120 | |
| 13 | 1996 | 29 | |
| 14 | 1996 | 169 | |
| 15 | 1995 | 22 | |
| 16 | 1994 | 40 | |
| 17 | 1993 | 27 | |
| 18 | 1993 | 23 | |
| 19 | 1990 | 29 | |
| 20 | 1990 | 25 |
About Tomoyuki Sumizawa
Tomoyuki Sumizawa is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 94 papers that have together received 4.6k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (54 papers), Cancer therapeutics and mechanisms (12 papers), Cancer, Hypoxia, and Metabolism (11 papers), Pharmacological Effects and Toxicity Studies (10 papers), Glycosylation and Glycoproteins Research (7 papers), DNA Repair Mechanisms (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Cancer-related Molecular Pathways (7 papers). The work is most often cited by research in Oncology (2.7k citations), Cancer Research (813 citations) and Molecular Biology (2.2k citations). Tomoyuki Sumizawa has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Tatsuhiko Furukawa, Shin‐ichi Akiyama, Zhe‐Sheng Chen, Misako Haraguchi, Shin-ichi Akiyama, Takashi Aikou, Kazutaka Miyadera, S Akiyama, Yuji Yamada and Shin‐ichi Akiyama. Their work appears in journals such as Science, Journal of Biological Chemistry and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.